Friday, 21 February 2020

Japan News

  • Verastem enters research collaboration with Eisai

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2012

    Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced a research collabora...Read more

  • CRO INC Research expands to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Therapeutically focused global clinical research organization, INC Research LLC has announced the establishment of INC Research Japan KK. The firm has opened in two new areas, Os...Read more

  • Sosei initiates oropharyngeal candidiasis trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis. The study is an open-label, randomised, multiple centr...Read more

  • Japan study: Sugar solution makes tissue transparent

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based solution that turns tissues transparent in just three days, without dis...Read more

  • Astellas, Cytokinetics sign $490 mn muscle deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&D and commercialization of skeletal muscle activators. The primary ...Read more

  • Astellas, XenoPort launch Regnite in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite is approved in Japan for the treatment of moderate-to-severe primary r...Read more

  • TSRI, Takeda expand research collaboration

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Japanese I'rom acquires 18% in Australian IDT

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

  • Iressa deaths: Japanese High Court rules in favor of AZ

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for the deaths of several individuals due to the side effects of the firm'...Read more

  • Asia vaccine strategists call for collaboration

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more

  • RIKEN's new chip detects traces of miRNA in only 20 mins

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Singapore: A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan, has enabled the detection of microRNA from extremely small sample vol...Read more

  • Hoya appoints new executive officer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and head of corporate development and affairs. As the company's first c...Read more

  • Takeda's center among Chicago's top 100 workplaces

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago Tribune. The list of the best places to work in the Chicago area is ba...Read more

  • Eisai launches beauty drink in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'. The drink will contain Niacin and would be available at convenience...Read more

  • Eisai seeks nod for Helicobacter Pylori treatment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare for approval of two types of new ...Read more

  • Will Keryx's ferric citrate NDA get nod in Japan?

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare...Read more

  • FDA accepts sNDA for Astellas cancer drug

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally adv...Read more